We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
DC-CIK 与结直肠癌患者预后的关系和影响因素.
- Authors
操跃; 杨喜晶; 周福平; 张迁; 钱其军
- Abstract
Objective To discuss dendritic cell-cytokine-induced killer (DC-CIK) cell therapy effects and clinical outcomes in patients with colorectal cancer in order to have better clinical treatment. Methods A retrospective analysis of the data of 66 patients with colorectal cancer from the Biological Therapy Department of the Eastern Hepatobiliary Surgery Hospital was performed from January 2012 to January 2014, and then was followed up. Taking gender, age, degree of pathological differentiation, TNM staging, surgical methods, and targeted therapy as the research basis, by the Kaplan-Meier single factor and Cox multiple factors analysis we mainly discuss the DC-CIK cell treatment's effect on the prognoses of patients. Results Kaplan-Meier single factor analysis results indicate: to a certain extent, DC-CIK cell therapy can improve the prognoses of patients; Cox multi-factor analysis results indicate whether accepting DC-CIK cell therapy is an independent factor influencing the prognoses of patients. Conclusion DC-CIK cells therapy can improve the prognoses of patients with colorectal cancer.
- Publication
Journal of Pharmaceutical Practice & Service, 2016, Vol 34, Issue 4, p366
- ISSN
1006-0111
- Publication type
Article
- DOI
10.3969/j.issn.1006-0111.2016.04.022